Rapid Decrease of Intact Parathyroid Hormone Could Be a Predictor of Better Response to Cinacalcet in Hemodialysis Patients

PURPOSE: Cinacalcet is effective for treating refractory secondary hyperparathyroidism (SHPT), but little is known about the response rates and clinical factors influencing the response. MATERIALS AND METHODS: A prospective, single-arm, multi-center study was performed for 24 weeks. Cinacalcet was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa-Kyung, Kwon, Young Joo, Kim, Soo Wan, Kim, Yeong-Hoon, Park, Cheol Whee, Choi, Kyu Bok, Hwang, Seung Duk, Choi, Kyu Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575968/
https://www.ncbi.nlm.nih.gov/pubmed/23364981
http://dx.doi.org/10.3349/ymj.2013.54.2.453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575968/
https://www.ncbi.nlm.nih.gov/pubmed/23364981
http://dx.doi.org/10.3349/ymj.2013.54.2.453

Ejemplares similares